ArticleSchizophrenia (Heidelberg, Germany)2025
The shared genetic architecture between schizophrenia and common peripheral organ imaging phenotypes.
Article in Schizophrenia (Heidelberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Schizophrenia (SCZ) is a complex neuropsychiatric disorder that profoundly disrupts daily life. Beyond its well-documented effects on the brain, SCZ is also associated with peripheral organ dysfunction, yet the underlying shared genetic mechanisms remain unclear. In this study, leveraging large-scale genome-wide association study (GWAS) data, we investigated the genetic architecture shared between SCZ and 47 common imaging phenotypes spanning three major peripheral organs: 28 cardiac magnetic resonance (CMR) phenotypes, eight skeletal dual-energy X-ray absorptiometry (DXA) phenotypes, and 11 abdominal magnetic resonance imaging (MRI) phenotypes. We identified seven significant causal associations between SCZ and peripheral organ imaging phenotypes, alongside 99 unique loci through local genetic correlation analysis. Additionally, we pinpointed 437 independent pleiotropic SNPs between SCZ and CMR phenotypes, 257 for skeletal DXA phenotypes, and 230 for abdominal MRI phenotypes. The shared genes were significantly enriched in synapse-related biological processes, underscoring their vital role in SCZ across various peripheral organ systems. Furthermore, we characterized the spatiotemporal expression patterns of shared genes in the brain across different peripheral imaging phenotype groups and identified drug-gene interactions, highlighting potential therapeutic targets for SCZ-related peripheral dysfunction. Our findings underscore the systemic nature of SCZ, emphasizing the need to integrate psychiatric and systemic health perspectives in its management. By revealing novel genetic links and potential therapeutic targets, this study provides valuable insights into SCZ's multifaceted impact beyond the brain.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.